Fundraising FoxFreeline
4 known investors
Find your way into Freeline
Sign up to see every warm intro you have to Freeline
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Freeline team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Freeline develops gene therapies aimed at stopping the progression of chronic diseases with single-dose genetic medicines. Its pipeline spans rare conditions such as Gaucher disease and moves toward more widespread conditions including forms of Parkinson's, dementia, and certain cardiovascular diseases.
Investors · 4
Frequently asked questions
- What does Freeline do?
- Freeline develops gene therapies aimed at stopping the progression of chronic diseases with single-dose genetic medicines. Its pipeline spans rare conditions such as Gaucher disease and moves toward more widespread conditions including forms of Parkinson's, dementia, and certain cardiovascular diseases.
- Who are Freeline's investors?
- Freeline's investors include AlbionVC, Invivo Capital Partners, Wellington Management, UCL Technology Fund.